共 10 条
- [1] Currentstatusandprospectsoflivevaricellavaccine. TakahashiM. Vaccine . 1992
- [2] Safetyandimmunogenicityofonevs.twoinjectionsofOka/Merckvaricellavaccineinhealthychildren. NagiAL,StaehleBO,KuterBJ,etal. PediatrInfectDisJ . 1996
- [3] Sensitiveenzyme -linkedimmunosorbentassayforantibodytovaricella -zostervirususingpurifiedVZV glycoproteinantigen. WasmuthEH,MillerWJ. JMedVirol . 1990
- [4] Dosetitrationstudyofliveattenuatedvaricellavaccineinhealthychildren. RothsteinEP,BernsteinHH,NagiAL,etal. The Journal of Infectious Diseases . 1997
- [5] Varicellavaccine:theJapaneseexperience. AsanoY. The Journal of Infectious Diseases . 1996
- [6] Liveattenuatedvaccineusedtopreventthespreadofvaricellainchildreninhospital. TakahashiM,OtsukaT,OkunoY,etal. The Lancet . 1974
- [7] Immunitytowholevaricella -zostervirusantigenand glycoproteinIand p170 :Relationtotheimmunizingregimenofliveattenuatedvaricellavaccine. NdumbePS. JMedVirol . 1988
- [8] Immunogenicityandsafetyofliveattenuatedvaricella(Oka /SBBio)inhealthychildren. MeuriceF,DeBouverJL,VandevoordeD,etal. The Journal of Infectious Diseases . 1996
- [9] UseofareformulatedOkastrainvaricellavaccine (SmithKlineBeechamBiologicals /Oka)inhealthychildren. TanAY,ConnettCJ,ConnettGJ,etal. European Journal of Pediatrics . 1996
- [10] Developmentofaliveattenuatedvaricellavaccine. TakahashiM,OkunoY,OtsukaT,etal. BikenJ . 1975